Back to Gastroenterology
GastroenterologyvRome IV (2016)Evidence-Based

Rome IV Diagnostic Criteria for Proctalgia Fugax

Official Rome IV diagnostic criteria for proctalgia fugax, a functional anorectal pain disorder characterized by sudden, severe, episodic rectal pain unrelated to defecation. This validated diagnostic tool helps differentiate proctalgia fugax from other anorectal pain syndromes including levator ani syndrome and unspecified functional anorectal pain.

Clinical Input Parameters

Clinical Assessment
Awaiting Parameters
rome iv proctalgia fugax diagnosis
—diagnosis
Ready to Calculate

Awaiting Clinical Input

Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.

Open in Web App
Clinical decision support tool for licensed medical practitioners. Confirm independently before prescribing or clinical action.

When & Why to Use

The Rome IV Diagnostic Criteria for Proctalgia Fugax is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within gastroenterology.

Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.

Clinical Formula & Scoring Logic

Rome IV Proctalgia Fugax Diagnosis = ALL criteria must be met: (1) Recurrent rectal pain unrelated to defecation + (2) Episodes lasting seconds to 30 minutes + (3) No pain between episodes + (4) Exclusion of all organic causes (IBD, structural lesions, prostatitis, coccygodynia, pelvic floor alterations)

Clinical Pearls & Practice Notes

  • Rome IV diagnostic criteria for functional gastrointestinal disorders
  • All criteria must be fulfilled for positive diagnosis
  • Proctalgia fugax is characterized by sudden, severe, episodic rectal pain
  • Maximum episode duration increased from 20 to 30 minutes in Rome IV vs Rome III
  • Pain location specified as rectum (not lower rectum/anus as in Rome III)
  • Distinct from levator ani syndrome (chronic pain with puborectalis tenderness)
  • Distinct from unspecified functional anorectal pain (episodes >30 minutes)
  • Episodes typically occur <5 times per year in most patients
  • Pain often described as sudden, severe, cramping, or stabbing
  • Can awaken patients from sleep and interrupt normal activities
  • May be triggered by stress, anxiety, or sexual activity
  • Diagnosis of exclusion requiring thorough evaluation for organic causes
  • Treatment is primarily symptomatic and supportive
  • Reassurance and stress management are important therapeutic components

Evidence & Literature Citations

  1. Lacy BE, Mearin F, Chang L, Chey WD, Lembo AJ, Simren M, Spiller R. Bowel Disorders. Gastroenterology. 2016 May;150(6):1393-1407.e5. doi: 10.1053/j.gastro.2016.02.031.
  2. Bharucha AE, Wald A, Enck P, Rao S. Functional anorectal disorders. Gastroenterology. 2006 Apr;130(5):1510-8. doi: 10.1053/j.gastro.2005.11.064.
  3. Rome Foundation. Rome IV Diagnostic Criteria for Functional Gastrointestinal Disorders. 4th ed. Raleigh, NC: Rome Foundation; 2016.
  4. Chiarioni G, Asteria C, Whitehead WE. Chronic proctalgia and chronic pelvic pain syndromes: new etiologic insights and treatment options. World J Gastroenterol. 2011 Oct 21;17(39):4447-55. doi: 10.3748/wjg.v17.i39.4447.

Score Interpretation Ranges

Criteria Not Met0 – 0 pts

Does not meet Rome IV criteria

Criteria Met1 – 1 pts

Meets Rome IV criteria

Need Clinical Suite Access?

Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.

Open in Web App

Clinical Decision Support (CDS) Notice & Legal Disclaimer

This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.